MKI67 and neoplasm: This treatment also led to a significant decrease in tumor growth rate and a reduction in Ki67 expression levels in PDAC tissues from both the KPC allografts and patient-derived xenograft (PDX) models (Figures 2F–2H, S4C, and S4D).